Maternal Antibody at Delivery Protects Neonates From Early Onset Group B Streptococcal Disease
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Further reduction in the group B streptococcal (GBS) disease burden in neonates in the United States awaits an additional prevention strategy, such as maternal immunization. METHODS: We performed a prospective, multicenter, case-control study of 33 mothers delivering neonates with early onset GBS infection (cases), and 99 age- and ethnicity-matched mothers colonized with the same capsular polysaccharide (CPS) types delivering healthy neonates (controls). Relative risk and absolute risk were calculated for early onset disease associated with concentrations of type Ia, III, or V CPS-specific antibody in maternal serum. RESULTS: For GBS types Ia and III, maternal CPS-specific antibody concentrations of ≥ 0.5 µg/mL were associated with a relative risk of approximately 0.1 (95% confidence intervals [CIs], .01-.74 and 0-.72, respectively; P = .02 for each), corresponding to a 90% risk reduction (by logistic regression). For type V, the relative risk was 0.3 (95% CI, .01-3.1), corresponding to a 70% risk reduction. By Bayesian modeling, the risk of early onset disease would decrease by 70% if maternal CPS-specific antibody concentrations for these 3 GBS types were ≥ 1 µg/mL. CONCLUSIONS: Maternal CPS-specific antibody serum concentrations of ≥ 1 μg/mL at the time of delivery appear to protect most neonates from early onset GBS type Ia and III disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Management of Infants at Risk for Group B Streptococcal Disease
Puopolo, K. M., Lynfield, R., Cummings, J. J., COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON INFECTIOUS DISEASES, Hand, I., Adams-Chapman, I., Poindexter, B., Stewart, D. L., Aucott, S. W., et al. (2019) · Pediatrics · doi:10.1542/peds.2019-1881 · Cited by 317
Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology
Shabayek, S., & Spellerberg, B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00437 · Cited by 291
Updates on immunologic correlates of vaccine-induced protection
Plotkin, S. A. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.10.046 · Cited by 165
Status of vaccine research and development of vaccines for GBS
Heath, P. T. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.12.072 · Cited by 152
Kobayashi, M., Schrag, S. J., Alderson, M. R., Madhi, S. A., Baker, C. J., Sobanjo-ter Meulen, A., Kaslow, D. C., Smith, P. G., Moorthy, V. S., & Vekemans, J. (2019) · Vaccine · doi:10.1016/j.vaccine.2016.12.029 · Cited by 105
Self-citation
Metadata
- Authors
- Baker, C. J., Carey, V. J., Rench, M. A., Edwards, M. S., Hillier, S. L., Kasper, D. L., & Platt, R.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-16
- Volume
- 209
- Issue
- 5
- Pages
- 781-788
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2142804604
- Cited by
- 138
- References
- 0
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.